1. Effects of caffeic acid phenethyl ester on lipopolysaccharide-induced lung injury in rats.
- Author
-
Koksel O, Ozdulger A, Tamer L, Cinel L, Ercil M, Degirmenci U, Unlu S, and Kanik A
- Subjects
- Animals, Antioxidants metabolism, Lung metabolism, Lung pathology, Male, Malondialdehyde metabolism, Peroxidase biosynthesis, Phenylethyl Alcohol therapeutic use, Rats, Rats, Wistar, Respiratory Distress Syndrome chemically induced, Respiratory Distress Syndrome pathology, Sodium-Potassium-Exchanging ATPase biosynthesis, Anti-Inflammatory Agents therapeutic use, Antioxidants therapeutic use, Caffeic Acids therapeutic use, Lipopolysaccharides, Phenylethyl Alcohol analogs & derivatives, Respiratory Distress Syndrome drug therapy
- Abstract
Extracts of propolis, a natural beehive product, have been known for centuries to have a variety of beneficial medical properties, among which their anti-inflammatory effect is a major one. Caffeic acid phenethyl ester (CAPE), an active propolis component, has antimicrobial, anti-inflammatory, antioxidant, carcinostatic and immunomodulatory properties. In this study, we aimed to investigate the efficacy of CAPE in endotoxin-induced lung injury in rats. Lung injury was induced by a footpad injection of lipopolysaccharide (LPS). In the treatment group, 10 micromol kg(-1) CAPE was injected intraperitoneally immediately after LPS injection. At 24 h after LPS and/or CAPE injection, blood and lung tissue specimens were collected. MDA levels and MPO activity in serum and lung tissue, serum total antioxidant levels, lung tissue Na(+)/K(+) ATP-ase activity and histopathological evaluation were determined to assess the efficacy of CAPE treatment. CAPE was found to be efficient in reducing inflammation and lung tissue damage induced by LPS in rats.
- Published
- 2006
- Full Text
- View/download PDF